Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
Cancer treatment has entered the era of precision medicine, where knowledge of a patient's genetic profile is used to facilitate early diagnosis, drug selection, prognosis, prediction of drug responsiveness, the onset of secondary resistance, and relapse. Circulating free DNA (cfDNA) has emerge...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f443e279774f4ecf8cda2b1b13aa8425 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|